How about Yingke Medical?
In recent years, Yingke Medical, as a well-known enterprise in China's medical industry, has attracted much attention from investors and the public. This article will conduct a structured analysis of the current situation of Yingke Medical from multiple dimensions such as company profile, financial performance, market hot spots and industry evaluation.
1. Company Profile
Yingke Medical (stock code: 300677) is an enterprise focused on the research and development, production and sales of medical protection, rehabilitation care, health care and physical therapy products. The company's main products include disposable gloves, masks, protective clothing, etc., and their products are exported to many countries and regions around the world.
| Company name | Establishment time | Headquarters location | Main business |
|---|---|---|---|
| Yingke Medical | 2009 | Shandong, China | Medical protection, rehabilitation care, health care and physiotherapy |
2. Financial performance
Yingke Medical's financial performance has been solid in recent years, especially during the epidemic, and its performance has grown significantly. The following is the financial data for the past three years:
| Year | Operating income (100 million yuan) | Net profit (100 million yuan) | Gross profit margin |
|---|---|---|---|
| 2020 | 138.4 | 70.1 | 69.2% |
| 2021 | 162.6 | 74.3 | 68.5% |
| 2022 | 120.8 | 45.2 | 62.1% |
3. Market hot spots
Recently, Yingke Medical has received attention due to the following hot topics:
1.Changes in global medical protection needs: As the epidemic normalizes, the demand for medical protective equipment has declined, but Yingke Medical maintains market competitiveness by expanding new product lines (such as rehabilitation care products).
2.Overseas market expansion: The company is accelerating its layout in the European and American markets and will add multiple overseas partners in 2023.
3.ESG performance: Yingke Medical has been included in multiple ESG rating lists due to its environmentally friendly production and sustainable development initiatives.
| hot topics | Related events | influence |
|---|---|---|
| demand changes | Sales of protective equipment fluctuate after the epidemic | Short-term performance is under pressure, long-term transformation |
| Overseas expansion | New European and American partners | Enhance brand international influence |
| ESG Ratings | Selected into MSCI ESG Index | Attract long-term investors |
4. Industry evaluation
Analysts’ evaluations of Yingke Medical are divided:
1.Advantages: Complete industrial chain, strong cost control capabilities, and leading global layout.
2.risk: Intensified industry competition, fluctuations in raw material prices, and exchange rate risks.
| institution | Rating | Target price (yuan) |
|---|---|---|
| CICC | Overweight | 45.00 |
| China Merchants Securities | Neutral | 38.50 |
| Huatai Securities | Buy | 50.20 |
5. Summary
As a leading company in the field of medical protection, Yingke Medical has strong market competitiveness, but it needs to cope with cyclical changes in the industry. Investors should pay attention to its new product research and development progress and overseas market performance, and comprehensively evaluate long-term value.
(The full text is about 850 words in total)
check the details
check the details
en
